Cervical cancer is an urgent problem due to its high morbidity, its growth tendency in women of reproductive age, and late presentation. As a result of insufficiently effective surgical and/or radiation treatment of the primary tumor, local recurrences occur in 10-40% of treated patients, and distant metastases in 35% of patients [10]. The first place according to the frequency of distant metastasis in RCC patients is occupied by para-aortic lymph nodes (31.2%), the second - lungs (16.1%), the third - bones (12.9%) [9]. Treatment of recurrent and generalized cervical cancer is a complex and unresolved problem of modern oncology due to the extremely limited range of possible therapeutic measures. The leading role in conservative therapy of cervical cancer relapses and metastases is played by highly toxic, but not specific cytostatics, which aggravates the condition of patients and the immunological failure of the organism [11].

Cervical cancer, marker recurrence, SD-3,, SD20, biopsy, retrospective study

Hatch D. K., FU Y. S., (2009). Cervical and vaginal cancer. In: BEREK J. S. (ed), Novak’s Gynecology, Callisto Medical Press, Turkey, 1111–1155.

Monie A., Hung C. F., Wu T. C. (2017). Preventive and therapeutic HPV vaccines, Curr Opin Invest Drugs, 8(12), 1038–1050.

Gonçalves, M. A. G., & Donadi, E. A. (2004). Immune cellular response to HPV: current concepts. Brazilian Journal of Infectious Diseases, 8(1), 1-9.

Bethwaite, P. B., Holloway, L. J., Thornton, A., & Delahunt, B. (1996). Infiltration by immunocompetent cells in early stage invasive carcinoma of the uterine cervix: a prognostic study. Pathology, 28(4), 321-327.

Bell, M. C., Edwards, R. P., Partridge, E. E., Kuykendall, K., Conner, W., Gore, H., ... & Crowley-Nowick, P. A. (1995). CD8+ T lymphocytes are recruited to neoplastic cervix. Journal of clinical immunology, 15(3), 130-136.

Chao, H. T., Wang, P. H., Tseng, J. Y., Lai, C. R., Chiang, S. C., & Yuan, C. C. (1999). Lymphocyte-infiltrated FIGO Stage IIB squamous cell carcinoma of the cervix is a prominent factor for disease-free survival. European journal of gynaecological oncology, 20(2), 136-140.

Shomurodov. K.E. (2010). Features of cytokine balance in gingival fluid at odontogenicphlegmon of maxillofacial area. Doctor-aspirant. 42 Vol. No.5.1. P.187-192.

Tillyashaykhov, M. N. (2019). Rakhimov NM Khasanov Sh. T., Features of Clinical Manifestation of the bladder cancer in young people. Doctor Bulletin.-Samarkand, 2, 108-113.

Ilkhomovna, K. M., Eriyigitovich, I. S., & Kadyrovich, K. N. (2020). Morphological Features Of Microvascular Tissue Of The Brain At Hemorrhagic Stroke. The American Journal of Medical Sciences and Pharmaceutical Research, 2(10), 53-59.

Ziyadullaev, S., Elmamatov, O., Raximov, N., & Raufov, F. (2020). Cytogenetic and immunological alterations of recurrent bladder cancer. European Journal of Molecular & Clinical Medicine, 7(2), 1877-1883.

Tillyashaykhov M, Rakhimov N, Boyko E, Ravshan Kh (2020). Comparative characteristics of en-block resection and conventional transurethral resection in nonmuscular invasive bladder cancer (metaanalysis). Journal of Biomedicine and Practice, vol. 6, issue 5, pp.124-131.

Rahimov M. Nodir, Shakhanova Sh. Shaxnoza, Raupov Farhod. (2020). Development of new approaches in treatment of metastatic renal cell carcinoma. Journal of research in health science. 5(4), 82-95.

Saidkulov, B., Abduraxmonov, A., & Rahimov, N. (2020). Recurrent ovarian cancer: mechanisms of development of peritoneal malignant ascites. European Journal of Molecular & Clinical Medicine ISSN, 2515-8260.

Nedergaard, B. S., Ladekarl, M., Thomsen, H. F., Nyengaard, J. R., & Nielsen, K. (2007). Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer. British journal of cancer, 97(8), 1135-1138.